Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Connect Biopharma Holdings Limited (CNTB)

NASDAQ

$2.84

$-0.15

(-4.85%)

Connect Biopharma Holdings Limited (CNTB) Live Price Chart

Page last updated: 2026-04-17 23:57:00

Key Market Data

Market Cap	$160.58M
Open	$3.05
High	$29.27
Low	$0.51
Previous Close	$2.99
Price Change	$-0.15
Percentage Change	-4.85%
Volume	380K

Connect Biopharma Holdings Limited (CNTB) Stock Price Today

Connect Biopharma Holdings Limited (CNTB) is currently trading at $2.84 as of 2026-04-17 23:57:00, reflecting a -4.85% move ($-0.15) from the previous close.

In the short term, the stock has returned -1.01% over the past four weeks. Over the last 12 months, Connect Biopharma Holdings Limited has recorded a +284.33% price change, indicating a Strong performance relative to the broader market.

Connect Biopharma Holdings Limited (CNTB) 7-Day Stock Price Changes

Over the past seven days, Connect Biopharma Holdings Limited has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $2.81 to the latest recorded price of $2.84, reflecting an intraday change of -4.85%. Daily movements highlight shifts in trading volume (379,782), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, CNTB has delivered a -1.01% return over the past month and a +284.33% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.

How to Buy Connect Biopharma Holdings Limited (CNTB)

You can buy and trade CNTB on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for CNTB and Execute Your Trade

Open the trading page, enter CNTB in the search bar, select the amount of CNTB you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Connect Biopharma Holdings Limited (CNTB)?

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Connect Biopharma Holdings Limited Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	64
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.connectbiopharm.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Connect Biopharma Holdings Limited?

The latest trading price for Connect Biopharma Holdings Limited (Common Stock) is $ 2.84, compared with a previous closing price of $ 2.99. That means the stock has moved -4.85% so far today. Intraday price updates and recent trading activity for CNTB can be tracked on the live chart and quote section on this page.

2.Is Connect Biopharma Holdings Limited stock going up or down?

Looking at recent performances, CNTB has returned -1.01% over the past month, +61.42% over the last six months and +284.33% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Strong price momentum for Connect Biopharma Holdings Limited stock, but keep in mind that past returns do not guarantee future results.

3.Where does CNTB currently sit relative to its 52-week high and low?

In the most recent 52-week period, Connect Biopharma Holdings Limited has traded between a low of $ 0.65 and a high of $ 3.82. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether CNTB is currently nearer the top or the bottom of its one-year trading band.

4.How is Connect Biopharma Holdings Limited classified by sector and industry?

Connect Biopharma Holdings Limited is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means Connect Biopharma Holdings Limited is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing CNTB’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence Connect Biopharma Holdings Limited’s performance.

5.Where is Connect Biopharma Holdings Limited listed and how large is it by market value?

Connect Biopharma Holdings Limited is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 160.58M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Connect Biopharma Holdings Limited's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does CNTB's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.99 summarises how much profit Connect Biopharma Holdings Limited has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Connect Biopharma Holdings Limited's financial performance over time?

To follow Connect Biopharma Holdings Limited's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how CNTB is performing and how the market is responding.

8.When is Connect Biopharma Holdings Limited expected to report earnings?

Connect Biopharma Holdings Limited's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for CNTB, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Connect Biopharma Holdings Limited's earnings reports?

Connect Biopharma Holdings Limited's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether CNTB is meeting, beating or missing expectations.

10.How can I stay informed about Connect Biopharma Holdings Limited's results and guidance?

You can stay up to date on Connect Biopharma Holdings Limited by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for CNTB on this page helps you see how new information is being reflected in the stock.

11.Does Connect Biopharma Holdings Limited pay a regular cash dividend to its shareholders?

Connect Biopharma Holdings Limited Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor CNTB's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for CNTB?

Based on the latest earnings data, CNTB has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Connect Biopharma Holdings Limited is an attractive income stock. The dividend payout ratio measures what percentage of earnings Connect Biopharma Holdings Limited distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Connect Biopharma Holdings Limited?

Connect Biopharma Holdings Limited is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is CNTB valued in terms of P/E ratio and EPS?

Connect Biopharma Holdings Limited currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.99. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Connect Biopharma Holdings Limited's earnings. Comparing CNTB's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Mawson Infrastructure Group Inc.

MIGI

Canopy Growth Corporation

CGC

The Kraft Heinz Company

KHC

Top Gainers

Browse today's leading gainers in the US stock market

Energy Focus, Inc.

EFOI

Forum Markets, Incorporated

FRMM

Beasley Broadcasting Group Inc.

BBGI

Psyence Biomedical Ltd

PBM

Blaize Holdings, Inc.

BZAI

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

CNTB-to-USD Calculator

Amount

CNTB

USD

1 CNTB = 2.841 USD